Completing data — usually done within a minute
Basic information
- Standard SMILES
O=C(NCCN1CCOCC1)c1ccc(Cl)cc1- InChIKey
YHXISWVBGDMDLQ-UHFFFAOYSA-N- Molecular formula
- C13H17ClN2O2
- Average molar mass
- 268.744 g/mol
- Monoisotopic mass
- 268.09785546
Names & identifiers
- Preferred name
- Moclobemide
- IUPAC
- 4-Chloro-N-[2-(morpholin-4-yl)ethyl]benzamide
- English name
- Moclobemide
- Molecular formula
- C13H17ClN2O2
- Molecular weight
- 268.74
Names & synonyms
Database identifiers
- CAS
71320-77-9- PubChem CID
- 4235
- DTXSID
DTXSID9040554- ChEMBL
CHEMBL86304- ChEBI
CHEBI:83531- UNII
- PJ0Y7AZB63
- EC Number
- 636-108-5
- Nikkaji
- J19.047K
Properties
Physicochemical properties
- Melting point
- 137 °C · 137°C
- Boiling point
- 447.7 · 447.7±40.0 °C(Predicted)
- Density
- 1.206 · 1.206±0.06 g/cm3(Predicted)
- storage temp.
- room temp
- solubility
- 20 mg/mL · DMSO: >20mg/mL
- pka
- 14.26 · 14.26±0.46(Predicted)
- form
- solid
- color
- white
- Merck
- 14 · 14,6226
- InChI
- InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)
- InChIKey
- YHXISWVBGDMDLQ-UHFFFAOYSA-N
- SMILES
- C(NCCN1CCOCC1)(=O)C1=CC=C(Cl)C=C1
- CAS DataBase Reference
- 71320 · 71320-77-9(CAS DataBase Reference)
- FDA UNII
- 0 Y7AZB63 · PJ0Y7AZB63
- ATC code
- 6 AG02 · N06AG02
- NIST Chemistry Reference
- Moclobemide(71320-77-9)
- UNSPSC Code
- 12352200 · 12352200
- NACRES
- 77 · NA.77
- Protein binding
- 50 % · 50%
- Excreted unchanged in urine
- 1 % · <1%
- Volume of distribution
- 1 · 1(L/kg)
- Biological half-life
- 2 · 2-4 / Unchanged
- Symbol(GHS)
- 5 · GHS05,GHS07
- Signal word
- Danger
- Hazard statements
- 302 · H302-H315-H318-H335
- Precautionary statements
- 280 · P280-P301+P312+P330-P302+P352-P305+P351+P338+P310
- target organs
- Respiratory system
- PPE
- 95 · dust mask type N95 (US), Eyeshields, Gloves
- Hazard Codes
- Xn,T+
- Risk Statements
- 22 · 22-37/38-41-26/27/28
- Safety Statements
- 26 · 26-39-45-36/37/39-22
- RIDADR
- 3249 · 3249
- WGK Germany
- 2 · 2
- RTECS
- 2462000 · CV2462000
- HazardClass
- 6.1 · 6.1(b)
- PackingGroup
- III
- HS Code
- 29349990 · 29349990
- Storage Class
- 11 · 11 - Combustible Solids
- Hazard Classifications
- 4 OralEye · Acute Tox. 4 OralEye Dam. 1Skin Irrit. 2STOT SE 3
- Hazardous Substances Data
- 71320 · 71320-77-9(Hazardous Substances Data)
- Toxicity
- 50 in · LD50 in rats (mg/kg): 707 orally (Burkard, Wyss)
Safety & regulation
Safety data
- PPE
- dust mask type N95 (US), Eyeshields, Gloves
- wgk
- 2
- rtecs
- CV2462000
- ridadr
- 3249
- hs_code
- 29349990
- Toxicity
- LD50 in rats (mg/kg): 707 orally (Burkard, Wyss)
- risk_code
- 22-37/38-41-26/27/28
- Signal word
- Danger
- Symbol(GHS)
- GHS05,GHS07
- hazard_code
- Xn,T+
- safety_code
- 26-39-45-36/37/39-22
- hazard_class
- 6.1(b)
- Storage Class
- 11 - Combustible Solids
- packing_group
- III
- target organs
- Respiratory system
- Hazard statements
- H302-H315-H318-H335
- Hazard Classifications
- Acute Tox. 4 OralEye Dam. 1Skin Irrit. 2STOT SE 3
- Precautionary statements
- P280-P301+P312+P330-P302+P352-P305+P351+P338+P310
- Hazardous Substances Data
- 71320-77-9(Hazardous Substances Data)
Chemistry & industry
Applications
DescriptionMoclobemide is the first of a new generation of non-hydrazine, reversible MAO-A inhibitors useful in the treatment of depression. Moclobemide is a selective inhibitor of MAO-A, allowing tyramine to be metabolized by MAO-B. In controlled studies, moclobemide was clinically superior to desipramine and showed no cholinergic or cardiovascular side-effects. A metabolite is currently under investigation for treatment of Parkinson’s disease,.
DescriptionMoclobemide (Item No. 24361) is an analytical reference standard categorized as an antidepressant. This product is intended for research and forensic applications.
UsesA reversible monoamine oxidase inhibitor.
UsesAntidepressant;Mono amine oxidase inhibitor (Type A)
Upstream & downstream products
Upstream raw materials
Suppliers50 total
Additional notes
DefinitionChEBI: A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Related reactions
Linked notes
Loading…